Infection control in the bronchoscopy suite: A review of outbreaks and guidelines for prevention

American Journal of Respiratory and Critical Care Medicine

Volumn 167, Issue 8, 2003, Pages 1050-1056

  Culver, Daniel A ^a   Gordon, Steven M ^a   Mehta, Atul C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; VIRUS DNA;

BRONCHOSCOPE; BRONCHOSCOPY; CLEANING; CONTAMINATION; DIAGNOSTIC PROCEDURE; DISEASE TRANSMISSION; DISINFECTION; ELECTROSURGERY; EPIDEMIC; EPIDEMIOLOGICAL DATA; FUNGUS; HAZARD ASSESSMENT; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION CONTROL; KLEBSIELLA; LASER SURGERY; MEDICAL LITERATURE; MEDICAL PERSONNEL; MICROORGANISM; MYCOBACTERIUM; NEBULIZER; NONHUMAN; NOTE; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROPHYLAXIS; PSEUDOMONAS AERUGINOSA; SERRATIA; SUCTION; TOPICAL ANESTHESIA; UNITED STATES; UPPER RESPIRATORY TRACT;

BRONCHOSCOPY; DISEASE OUTBREAKS; DISINFECTION; EQUIPMENT CONTAMINATION; EQUIPMENT REUSE; HUMANS; INFECTION; INFECTION CONTROL; OCCUPATIONAL DISEASES; PRACTICE GUIDELINES; RISK FACTORS;

EID: 0037447005     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200208-797CC     Document Type: Note

References (50)

1. Institute of Medicine (U.S.). To err is human. Washington, DC: National Academy Press; 2000.
2. Srinivasan A, Wolfenden LL, Song X, Mackie K, Hartsell TL, Jones HD, Diette GB, Orens JB, Yung RC, Ross TL, et al. An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes. N Engl J Med 2003;348:221-227.
3. Kirschke DL, Jones TF, Craig AS, Chu PS. Mayernick GG, Patel JA, Schaffner W. Pseudomonas aeruginosa and Serratia marcescens contamination associated with a manufacturing defect in bronchoscopes. N Engl J Med 2003;348:214-220.
4. Center for Disease Control. Vital and health statistics: ambulatory and inpatient procedures in the United States, 1996. Available online at: www.cdc.gov/nchs/data/13_139t9.pdf
5. Periera W Jr, Kovnat DM, Snyder GL. A prospective cooperative study of complications following flexible fiberoptic bronchoscopy. Chest 1978;73:813-816.
6. Mehta AC, Minai OA. Infection control in the bronchoscopy suite. Clin Chest Med 1999;20:19-32.
7. Agerton T, Valway S, Gore B, Pozsik C, Plikaytis B, Woodley C, Onorato I. Transmission of a highly drug-resistant strain (strain W1) of Mycobacterium tuberculosis. JAMA 1997;278:1073-1077.
8. Southwick KL, Hoffmann K, Ferree K, Matthews J, Salfinger M. Cluster of tuberculosis cases in North Carolina: possible association with atomizer reuse. Am J Infect Control 2001;29:1-6.
9. Sorin M, Segal-Maurer S, Mariano N, Urban C, Combest A, Rahal JJ. Nosocomial transmission of imipenem-resistant Pseudomonas aeruginosa following bronchoscopy associated with improper connection to the Steris System 1 processor. Infect Control Hosp Epidemiol 2001;22:409-413.
10. Centers for Disease Control and Prevention. Bronchoscopy-related infections and pseudoinfections - New York, 1996 and 1998. MMWR Morb Mortal Wkly Rep 1999;48:557-560.
11. Kaul K, Luke S, McGurn C, Snowden N, Monti C, Fry WA. Amplification of residual DNA sequences in sterile bronchoscopes leading to false-positive PCR results. J Clin Microbiol 1996;34:1949-1951.
12. Rutala W. Disinfection, sterilization and waste disposal. In: Wenzel R, editor. Prevention and control of nosocomial infections, 3rd ed. Baltimore, MD: Williams and Wilkins; 1997. p. 539-594.
13. Alfa MJ, DeGrange P, Olson N, Puchalski T. Comparison of ion plasma, vaporized hydrogen peroxide, and 100% ethylene oxide sterilizers to the 12/88 ethylene oxide gas sterilizer. Infect Control Hosp Epidemiol 1996;17:92-100.
14. Rutala WA, Weber DJ. Disinfection of endoscopes: review of new chemical sterilants used for high-level disinfection. Infect Control Hosp Epidemiol 1999;20:69-76.
15. Alvarado CJ, Reichelderfer M. APIC guideline for infection prevention and control in flexible endoscopy. Am J Infect Control 2000;28:138-155.
16. Alfa MJ, Sitter DL. In-hospital evaluation of orthophthalaldehyde as a high level disinfectant for flexible endoscopes. J Hosp Infect 1994;26:15-26.
17. Wheeler PW, Lancaster D, Kaiser AB. Bronchopulmonary cross-colonization and infection related to mycobacterial contamination of suction valves of bronchoscopes. J Infect Dis 1989;159:954-958.
18. Pappas SA, Schaff DM, DiCostanzo MB, King FW, Sharp JT. Contamination of flexible fiberoptic bronchoscopes. Am Rev Respir Dis 1983;127:391-392.
19. Ramsey AH, Oemig TV, Davis JP, Massey JP, Török TJ. An outbreak of bronchoscopy-related Mycobacterium tuberculosis infections due to lack of bronchoscope leak testing. Chest 2002;121:976-981.
20. Hoffmann KK, Weber DJ, Rutala WA. Pseudoepidemic of Rhodotorula rubra in patients undergoing fiberoptic bronchoscopy. Infect Control Hosp Epidemiol 1989;10:511-514.
21. Rutala WA. APIC guideline for selection and use of disinfectants. Am J Infect Control 1996;24:313-342.
22. Nelson KE, Larson PA, Schraufnagel DE, Jackson J. Transmission of tuberculosis by flexible fiberbronchoscopes. Am Rev Respir Dis 1983;127:97-100.
23. Hanson PJV, Chadwick MV, Gaya H, Collins JV. A study of glutaraldehyde disinfection of fibreoptic bronchoscopes experimentally contaminated with Mycobacterium tuberculosis. J Hosp Infect 1992;22:137-142.
24. Center for Devices and Radiologic Health-Food and Drug Administration. FDA-cleared sterilants and high level disinfectants with general claims for processing reusable medical and dental devices 1/30/02. Available online at: www.fda.gov/cdrh/ode/germlab.html
25. Mbithi JN, Springthorpe VS, Sattar SA, Pacquette M. Bactericidal, virucidal, and mycobactericidal activities of reused alkaline glutaraldehyde in an endoscopy unit. J Clin Microbiol 1993;31:2988-2995.
26. Centers for Disease Control and Prevention. Nosocomial infection and pseudoinfection from contaminated endoscopes and brorlchoscopes: Wisconsin and Missouri. MMWR Morb Mortal Wkly Rev 1991;40:675-678.
27. Schelenz S, French G. An outbreak of multidrug-resistant Pseudomonas aeruginosa infection associated with contamination of bronchoscopes and an endoscope washer-disinfector. J Hosp Infect 2000;46:23-30.
28. Bronowicki JP, Venard V, Botte C, Monhoven N, Gastin I, Chone L, Hudziak H, Rhin B, Delanoe C, LeFaou A, et al. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med 1997;337:237-240.
29. Birnie GG, Quigley EM, Clements GB, Follet EAC, Watkinson G. Endoscopic transmission of hepatitis B virus. Gut 1983;24:171-174.
30. Hanson PJV, Gor D, Clarke JR, Chadwick MV, Gazzard B, Jeffries DJ, Gaya H, Collins JV. Recovery of human immunodeficiency virus from fibreoptic bronchoscopes. Thorax 1991;46:410-412.
31. Bond WW, Favero MS, Petersen NJ, Ebert JW. Inactivation of Hepatitis B virus by intermediate-to-high level disinfectant chemicals. J Clin Microbiol 1983;18:535-538.
32. Collins FM. Bactericidal activity of alkaline glutaraldehyde solution against a number of atypical mycobacterial species. J Appl Bacteriol 1986;61:247-251.
33. Collins CH, Grange JM, Yates MD. Mycobacteria in water. J Appl Bacteriol 1984;57:193-211.
34. Jackson J, Leggett JE, Wilson D, Gilbert DN. Mycobacterium gordonae in fiberoptic bronchoscopes. Am J Infect Control 1996;24:19-23.
35. Mina B, Dym JP, Kuepper F, Tso R, Arrastia C, Kaplounova I, Faraj H, Kwapniewski A, Krol CM, Grosser M, et al. Fatal inhalational anthrax with unknown source of exposure in a 61-year-old woman in New York City. JAMA 2002;7:858-862.
36. Noy MF, Harrison L, Holmes GKT, Cockel R. The significance of bacterial contamination of fibreoptic endoscopes. J Hosp Infect 1980;1:53-61.
37. Vandenbroucke-Grauls CMJE, Baars ACM, Visser MR, Hulstaert PF, Verhoef J. An outbreak of Serratia marcescens traced to a contaminated bronchoscope. J Hosp Infect 1993;23:263-270.
38. Spraggs PD, Hanekom WH, Mochloulis G, Joseph T, Kelsey MC. The assessment of risk of cross-infection with a multi-use nasal atomizer. J Hosp Infect 1994;28:315-321.
39. Kaczmarek RG, Moore RM, McCrohan J, Goldmann DA, Reynolds C, Caquelin C, Israel E. Multi-state investigation of the actual disinfection/sterilization of endoscopes on health care facilities. Am J Med 1992;92:257-261.
40. Honeybourne D, Neumann CS. An audit of bronchoscopy practice in the UK: a survey of adherence to national guidelines. Thorax 1997;52:709-713.
41. Jereb JA, Berwen DR, Dooley SW, Haas WH, Crawford JT, Geiter LJ, Edmond MB, Dowling JN, Shapiro R, Pasculle AW, et al. Nosocomial outbreak of tuberculosis in a renal transplant unit: application of a new technique for restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates. J Infect Dis 1993;168:1219-1224.
42. Malasky C, Jordan T, Potulski F, Reichman LB. Occupational tuberculosis infections among pulmonary physicians in training. Am Rev Respir Dis 1990;142:505-507.
43. Catanzaro A. Nosocomial tuberculosis. Am Rev Respir Dis 1982;125:559-562.
44. Morice A. Hazard to bronchoscopists. Lancet 1989;1:448.
45. Centers for Disease Control and Prevention. Epidemiologic notes and reports update: human immunodeficiency virus infections in healthcare workers exposed to blood of infected patients. MMWR Morb Mortal Wkly Rep 1987;36:285-289.
46. Fennelly KP. Personal respiratory protection against Mycobacterium tuberculosis. Clin Chest Med 1997;18:1-17.
47. Sawchuk WS, Weber PJ, Lowy DR, Dzubow LM. Infectious papillomavirus in the vapor of warts treated with carbon dioxide laser or electrocoagulation: detection and protection. J Am Acad Dermatol 1989;21:41-49.
48. Baggish MS, Poiesz BJ, Joret D, Williamson P, Refai A. Presence of human immunodeficiency virus DNA in laser smoke. Lasers Surg Med 1991;11:197-203.
49. Gloster HM, Roenigk RK. Risk of acquiring human papillomavirus from the plume produced by the carbon dioxide laser in the treatment of warts. J Am Acad Dermatol 1995;32:436-441.
50. Lobraico RV, Schifano MJ, Brader KR. A retrospective study on the hazards of the carbon dioxide laser plume. J Laser Appl 1988;1:6-8.